Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
03692.HK stock price ended at $37.24 on Jueves, after dropping 1.90%
On the latest trading day Feb 12, 2026, the stock price of 03692.HK fell by 1.90%, dropping from $37.50 to $37.24. During the session, the stock saw a volatility of 4.18%, with prices oscillating between a daily low of $36.36 and a high of $37.88. On the latest trading day, the trading volume for 03692.HK rose by 1.7M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 7.4M shares were traded, with a market value of approximately $221.4B.
Señales Técnicas de 03692.HK
Resumen de Señales Técnicas
Señales de compra 0
Señales Neutras 2
Señales de venta 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
03692.HK actualmente presenta 0 señales de compra y 5 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -1.9% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Strong Sell para el mediano plazo.
Señales alcistas/bajistas para 03692.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 03692.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.